(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs ...

(Reuters) -Investment bank Lazard reported an 11% jump in second-quarter profit on Thursday, as a rebound in dealmaking ...

Despite compelling reasons for pessimism, the stock market continues to push higher. One might think that geopolitical tensions in the Middle East and Eastern Europe, strained relations with ...